Profile data is unavailable for this security.
About the company
HitGen Inc is a China-based company mainly engaged in the early research and development of original innovative drugs. The Company focuses on the research and creation of deoxyribonucleic acid encoded compound library (DEL) technology, research and development of hit compounds and lead compounds. The Company mainly provides DEL screening services, DEL library customization services, chemical synthesis services and transfer of new drug research and development projects. The Company conducts its businesses within the domestic market and to overseas markets.
- Revenue in CNY (TTM)409.13m
- Net income in CNY64.05m
- Incorporated2012
- Employees452.00
- LocationHitGen IncBlock 6,No.8 Huigu East 1st Road, Tianfu InternaCHENGDU 610200ChinaCHN
- Phone+86 2 885197385
- Fax+86 2 883310298
- Websitehttps://www.hitgen.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jiangsu Jibeier Pharmaceutical Co Ltd | 889.82m | 233.59m | 5.08bn | 1.45k | 21.60 | 2.59 | -- | 5.71 | 1.24 | 1.24 | 4.74 | 10.37 | 0.426 | 3.13 | 5.33 | 615,794.80 | 11.17 | 9.77 | 12.06 | 10.66 | 87.87 | 88.44 | 26.22 | 23.29 | 6.76 | -- | 0.005 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
Beijing Kawin Technol Sha-hld Co Ltd | 1.43bn | 117.53m | 5.16bn | 584.00 | 42.76 | 2.85 | -- | 3.60 | 0.7061 | 0.7061 | 8.61 | 10.60 | 0.6264 | 1.66 | 4.42 | 2,451,945.00 | 6.11 | 5.31 | 7.69 | 6.76 | 82.35 | 86.02 | 9.76 | 8.10 | 3.25 | -- | 0.0809 | 43.82 | 21.73 | 14.87 | 39.71 | 21.04 | 25.01 | -- |
Shanghai Haixin Group Co Ltd | 1.11bn | 171.70m | 5.23bn | 760.00 | 40.78 | 1.77 | -- | 4.71 | 0.1422 | 0.1422 | 0.9185 | 3.27 | 0.2246 | 7.19 | 9.32 | 1,458,849.00 | 4.05 | 2.68 | 4.57 | 3.06 | 46.37 | 44.55 | 18.02 | 11.17 | 2.83 | -- | 0.0089 | 36.10 | -17.88 | 1.48 | 1.20 | 4.19 | -10.27 | 13.18 |
HitGen Inc | 409.13m | 64.05m | 5.24bn | 452.00 | 82.09 | 3.80 | -- | 12.81 | 0.1593 | 0.1593 | 1.02 | 3.44 | 0.241 | 6.70 | 4.84 | 905,165.50 | 3.77 | 4.63 | 4.02 | 5.10 | 51.46 | 58.89 | 15.66 | 20.66 | 14.48 | 360.77 | 0.142 | 19.14 | 12.64 | 19.69 | 61.16 | -1.96 | -6.12 | -- |
Hunan Fangsheng Pharmaceutical Co Ltd | 1.63bn | 193.23m | 5.29bn | 1.69k | 27.17 | 3.44 | -- | 3.24 | 0.4428 | 0.4428 | 3.72 | 3.49 | 0.5227 | 1.48 | 6.56 | 966,866.90 | 5.93 | 5.39 | 9.72 | 9.37 | 67.75 | 66.91 | 11.34 | 8.95 | 0.5527 | 16.41 | 0.3447 | 46.47 | -9.12 | 9.15 | -34.64 | 20.68 | 23.91 | 4.75 |
Shanghai Hile Bio-Technology Co Ltd | 239.79m | 44.92m | 5.31bn | 295.00 | 120.63 | 4.25 | -- | 22.14 | 0.0669 | 0.0669 | 0.3664 | 1.90 | 0.154 | 1.06 | 2.40 | 812,857.50 | 2.06 | 1.73 | 2.56 | 2.47 | 45.19 | 50.44 | 13.37 | 10.37 | 1.16 | -- | 0.0562 | 23.89 | -19.76 | -1.11 | -48.30 | 24.17 | -41.32 | 23.47 |
InventisBio Co Ltd | 194.13m | -249.28m | 5.42bn | 221.00 | -- | 2.80 | -- | 27.92 | -0.4289 | -0.4289 | 0.3348 | 3.35 | 0.0898 | -- | 1.96 | 878,429.50 | -11.53 | -- | -12.26 | -- | 97.85 | -- | -128.41 | -- | -- | -- | 0.0054 | -- | -- | -- | 41.26 | -- | -- | -- |
Innovita Biological Technology Co Ltd | 625.12m | 266.22m | 5.52bn | 404.00 | 20.75 | 2.78 | -- | 8.83 | 1.96 | 1.96 | 4.59 | 14.62 | 0.3093 | 1.67 | 6.23 | 1,547,324.00 | 13.17 | -- | 14.20 | -- | 80.99 | -- | 42.59 | -- | 10.66 | -- | 0.0015 | -- | 7.03 | -- | 15.44 | -- | -- | -- |
Data as of May 17 2024. Currency figures normalised to HitGen Inc's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Da Cheng Fund Management Co., Ltd.as of 30 Jun 2023 | 1.67m | 0.42% |
Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2023 | 1.04m | 0.26% |
China Merchants Fund Management Co., Ltd.as of 30 Jun 2023 | 521.17k | 0.13% |
First-Trust Fund Management Co., Ltd.as of 30 Jun 2023 | 415.37k | 0.10% |
E Fund Management Co., Ltd.as of 30 Jun 2023 | 153.55k | 0.04% |
SSgA Funds Management, Inc.as of 04 Apr 2024 | 114.25k | 0.03% |
HFT Investment Management Co., Ltd.as of 30 Jun 2023 | 107.87k | 0.03% |
Harvest Fund Management Co., Ltd.as of 30 Jun 2023 | 6.00k | 0.00% |
GF Fund Management Co., Ltd.as of 30 Jun 2023 | 3.90k | 0.00% |
China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 824.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.